MeiraGTx Holdings plc Investing Cash Flow
MeiraGTx Holdings plc (MGTX) reported Investing Cash Flow of -$25.89 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-13
- MeiraGTx Holdings plc net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$23.64M.
- MeiraGTx Holdings plc net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$2.26M.
- MeiraGTx Holdings plc net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$1.09M.
- MeiraGTx Holdings plc net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$547.00K.
- MeiraGTx Holdings plc net cash provided by (used in) investing activities for fiscal 2025 was -$4.11M, a 117.49% decline from fiscal 2024.
- MeiraGTx Holdings plc net cash provided by (used in) investing activities for fiscal 2024 was $23.48M, a 31.01% decline from fiscal 2023.
- MeiraGTx Holdings plc net cash provided by (used in) investing activities for fiscal 2023 was $34.03M.
- MeiraGTx Holdings plc net cash provided by (used in) investing activities for fiscal 2022 was -$44.96M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 3 month as first filed | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 6 month as first filed | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$23.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$25.89M 10-Q · filed 2026-08-13 | -$26.98M derived: sum of 3 quarters · filed 2026-08-13 | -$27.53M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | -$2.26M 10-Q · filed 2026-05-14 | -$3.35M derived: sum of 2 quarters · filed 2026-05-14 | -$3.89M derived: sum of 3 quarters · filed 2026-05-14 | -$4.66M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | -$1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$1.64M derived: sum of 2 quarters · filed 2026-03-30 | -$2.40M derived: sum of 3 quarters · filed 2026-08-13 | -$4.11M 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | -$547.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$1.31M derived: sum of 2 quarters · filed 2026-08-13 | -$3.02M 10-Q · filed 2025-11-13 | -$4.24M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | -$761.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$2.47M 10-Q · filed 2026-08-13 | -$3.69M derived: sum of 3 quarters · filed 2026-08-13 | -$5.00M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | -$1.71M 10-Q · filed 2026-05-14 | -$2.93M derived: sum of 2 quarters · filed 2026-05-14 | -$4.24M derived: sum of 3 quarters · filed 2026-05-14 | -$5.57M derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | -$1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$2.53M derived: sum of 2 quarters · filed 2026-03-30 | -$3.86M derived: sum of 3 quarters · filed 2026-03-30 | $23.48M 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | -$1.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$2.64M derived: sum of 2 quarters · filed 2025-11-13 | $24.70M 10-Q · filed 2025-11-13 | $75.88M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | -$1.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $26.01M 10-Q · filed 2025-08-14 | $77.19M derived: sum of 3 quarters · filed 2025-08-14 | $73.63M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $27.34M 10-Q · filed 2025-05-13 | $78.52M derived: sum of 2 quarters · filed 2025-05-13 | $74.95M derived: sum of 3 quarters · filed 2025-05-13 | $69.98M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $51.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $47.61M derived: sum of 2 quarters · filed 2025-03-13 | $42.64M derived: sum of 3 quarters · filed 2025-03-13 | $34.03M 10-K · filed 2025-03-13 | ||||
| 2023-09-30 | -$3.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$8.54M derived: sum of 2 quarters · filed 2024-11-13 | -$17.14M 10-Q · filed 2024-11-13 | -$25.64M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | -$4.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$13.58M 10-Q · filed 2024-08-12 | -$22.07M derived: sum of 3 quarters · filed 2024-08-12 | -$32.08M derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | -$8.61M 10-Q · filed 2024-05-09 | -$17.10M derived: sum of 2 quarters · filed 2024-05-09 | -$27.11M derived: sum of 3 quarters · filed 2024-05-09 | -$41.11M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | -$8.49M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | -$18.50M derived: sum of 2 quarters · filed 2024-03-15 | -$32.50M derived: sum of 3 quarters · filed 2024-03-15 | -$44.96M 10-K · filed 2024-03-15 | ||||
| 2022-09-30 | -$10.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$24.01M derived: sum of 2 quarters · filed 2023-11-14 | -$36.47M 10-Q · filed 2023-11-14 | -$61.84M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | -$14.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$26.46M 10-Q · filed 2023-08-10 | -$51.83M derived: sum of 3 quarters · filed 2023-08-10 | -$63.73M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | -$12.46M 10-Q · filed 2023-05-11 | -$37.83M derived: sum of 2 quarters · filed 2023-05-11 | -$49.73M derived: sum of 3 quarters · filed 2023-05-11 | -$55.31M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | -$25.37M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | -$37.27M derived: sum of 2 quarters · filed 2023-03-14 | -$42.85M derived: sum of 3 quarters · filed 2023-03-14 | -$61.72M 10-K · filed 2023-03-14 | ||||
| 2021-09-30 | -$11.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$17.48M derived: sum of 2 quarters · filed 2022-11-10 | -$36.35M 10-Q · filed 2022-11-10 | -$46.58M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | -$5.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$24.44M 10-Q · filed 2022-08-11 | -$34.68M derived: sum of 3 quarters · filed 2022-08-11 | -$54.51M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | -$18.87M 10-Q · filed 2022-05-12 | -$29.10M derived: sum of 2 quarters · filed 2022-05-12 | -$48.94M derived: sum of 3 quarters · filed 2022-05-12 | -$51.85M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | -$10.23M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$30.07M derived: sum of 2 quarters · filed 2022-03-10 | -$32.98M derived: sum of 3 quarters · filed 2022-03-10 | -$37.02M 10-K · filed 2022-03-10 | -$37.02M 10-K · filed 2021-03-11 | |||
| 2020-09-30 | -$19.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$22.75M derived: sum of 2 quarters · filed 2021-11-10 | -$26.79M 10-Q · filed 2021-11-10 | -$26.79M 10-Q · filed 2020-11-05 | -$31.93M derived: sum of 4 quarters · filed 2021-11-10 | |||
| 2020-06-30 | -$2.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$6.95M 10-Q · filed 2021-08-11 | -$6.95M 10-Q · filed 2020-08-06 | -$12.09M derived: sum of 3 quarters · filed 2021-08-11 | -$14.12M derived: sum of 4 quarters · filed 2021-08-11 | |||
| 2020-03-31 | -$4.04M 10-Q · filed 2021-05-11 | -$4.04M 10-Q · filed 2020-05-07 | -$9.18M derived: sum of 2 quarters · filed 2021-05-11 | -$11.20M derived: sum of 3 quarters · filed 2021-05-11 | -$12.29M derived: sum of 4 quarters · filed 2021-05-11 | |||
| 2019-12-31 | -$5.14M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$7.16M derived: sum of 2 quarters · filed 2021-03-11 | -$8.25M derived: sum of 3 quarters · filed 2021-03-11 | -$9.37M 10-K · filed 2021-03-11 | ||||
| 2019-09-30 | -$2.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$3.12M derived: sum of 2 quarters · filed 2020-11-05 | -$4.23M 10-Q · filed 2020-11-05 | -$13.12M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | -$1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$2.21M 10-Q · filed 2020-08-06 | -$11.09M derived: sum of 3 quarters · filed 2020-08-06 | -$12.15M derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | -$1.12M 10-Q · filed 2020-05-07 | -$10.00M derived: sum of 2 quarters · filed 2020-05-07 | -$11.06M derived: sum of 3 quarters · filed 2020-05-07 | -$11.16M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | -$8.89M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | -$9.94M derived: sum of 2 quarters · filed 2020-03-11 | -$10.05M derived: sum of 3 quarters · filed 2020-03-11 | -$11.26M 10-K · filed 2020-03-11 | ||||
| 2018-09-30 | -$1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$1.16M derived: sum of 2 quarters · filed 2019-11-07 | -$2.37M 10-Q · filed 2019-11-07 | -$4.52M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | -$107.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$1.32M 10-Q · filed 2019-08-07 | -$3.46M derived: sum of 3 quarters · filed 2019-08-07 | -$9.53M derived: sum of 4 quarters · filed 2019-08-07 | ||||
| 2018-03-31 | -$1.21M 10-Q · filed 2019-05-14 | -$3.36M derived: sum of 2 quarters · filed 2019-05-14 | -$9.42M derived: sum of 3 quarters · filed 2019-05-14 | |||||
| 2017-12-31 | -$2.15M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | -$8.21M derived: sum of 2 quarters · filed 2019-03-26 | -$10.54M 10-K · filed 2019-03-26 | |||||
| 2017-09-30 | -$6.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$8.39M 10-Q · filed 2018-11-08 | ||||||
| 2017-06-30 | -$2.32M 10-Q · filed 2018-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |